In one study, decreased expression of PTPN2 in ER+ breast cancer was associated with increased expression of nuclear p-AKT, resulting in an overall poorer response to tamoxifen treatment in breast cancer [40]. The gene discussed is PTPN2; the disease is breast cancer.